Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation: a Randomized, Double-Masked, Placebo-Controlled, Cross-Over, 32 Weeks Study

NCT00505947 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT00505947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00505947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation: a Randomized, Double-Masked, Placebo-Controlled, Cross-Over, 32 Weeks Study
Lead sponsor
University of Athens
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2007
Completion date
December 31, 2008
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy, visual acuity